Trial Profile
A double-blind placebo-controlled two period crossover study of pregabalin and aprepitant in the electrical hyperalgesia model of central sensitisation in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Parecoxib (Primary) ; Pregabalin (Primary)
- Indications Fibromyalgia; Neuropathic pain; Pain
- Focus Therapeutic Use
- 04 Apr 2022 Status changed from recruiting to completed.
- 27 Jul 2011 New trial record